Medical/Pharmaceuticals
China Approves the World's First Vaccine against XBB Descendent Lineages of SARS-CoV-2 for Emergency Use
CHENGDU, China, June 9, 2023 /PRNewswire/ -- On June 8th, 2023, Coviccine® Trivalent XBB.1.5-Recombinant COVID-19 Trivalent (XBB.1.5+BA.5+Delta) Protein Vaccine (Sf9 cell) developed by WestVac Biopharma/ West China Medical Center, Sichuan University was approved for EUA by relevant authorities in ...
2023-06-09 11:59
3339
Investor Open Day: Fosun Implements Business Streamlining and Resilience Building Strategy, Focusing on Core Businesses to Bring New Vitality
HONG KONG, June 9, 2023 /PRNewswire/ -- On 8 June 2023, the 2023 Fosun International Investor Open Day was held inShanghai. It was the first time that Fosun International had held a large-scale offline open day after the pandemic. More than 100 domestic and foreign investor representatives from B...
2023-06-09 11:16
4736
LTS completes its entry into large molecule drug delivery with the acquisition of the Sorrel wearable injection device business
ANDERNACH, Germany, June 8, 2023 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS"), Oral Thin Films ("OTF") and Micro Array Patches ("MAP") has co...
2023-06-08 23:00
2918
DNAnexus® Applauded by Frost & Sullivan for Supporting Better Clinical Decision-making and More Effective Therapies
Since 2013, DNAnexus has led the market in cloud computing and bioinformatics platforms that handle complex data processing for genomics and multi-omics, counting more than 100 enterprise customers worldwide. SAN ANTONIO, June 8, 2023 /PRNewswire/ -- Frost & Sullivan's recent analysis of the pre...
2023-06-08 20:00
2586
Telix Opens European Radiopharmaceutical Production Facility
* Telix has unveiled its new, state-of-art radiopharmaceutical facility in Brussels South as part of its first stage investment of €14.1 million ($A21.2 million) * Located in Walloon's 'Radiopharma Valley' the facility will be a central hub for research and development for the region and f...
2023-06-08 20:00
2926
Qilu Pharmaceutical Announces Trials in Progress Posters on QL1706 in Phase III NSCLC Clinical Research at ASCO 2023
JINAN, China, June 8, 2023 /PRNewswire/ -- Recently, Qilu Pharmaceutical presented a Trials in Progress poster presentation on QL1706 (iparomlimab/tuvonralimab), an innovative bifunctional antibody for immunotherapy, in two Phase III non-small cell lung carcinoma (NSCLC) clinical studies at the ...
2023-06-08 15:35
2347
Generative Artificial Intelligence Tools Empowering Scientific Publications: Turacoz's Contribution to Medical Writing Industry
UTRECHT, Netherlands and NEW DELHI, June 7, 2023 /PRNewswire/ -- Turacoz embraces the transformative impact of generative AI in medical communications by actively participating in relevant events with both newcomers and professionals in the field. Recently, Dr.Namrata Singh, Founder and Director,...
2023-06-07 21:50
3406
NEC Thailand and Chiang Mai Municipality trial digital health platform to support elderly and patient care in Chiang Mai
CHIANG MAI, Thailand, June 7, 2023 /PRNewswire/ -- NEC Corporation (Thailand) Ltd. (NEC Thailand), has signed a Memorandum of Understanding (MoU) with Chiang Mai Municipality to develop smart city solutions and transformChiang Mai into a smart city, starting with a digital platform for the distri...
2023-06-07 17:30
2695
ACROBiosystems expands custom GMP-grade protein services to drive CGT development and commercialization
TOKYO, June 7, 2023 /PRNewswire/ -- Cell and gene therapy (CGT) is a cutting-edge therapy that combats cancer by bolstering the immune system through stem cell infusions or modified immune cells. However, manufacturing cell therapies isno easy feat. To support the commercialization of cell thera...
2023-06-07 16:05
2735
Gencurix Announces Clinical Research Results At ASCO Demonstrating Outstanding Performance of GenesWellBCT Compared to Global Best-Selling Test, OncotypeDX
SEOUL, South Korea, June 7, 2023 /PRNewswire/ -- Gencurix
2023-06-07 12:29
2771
BetaLife wins Cytiva's first BioChallenge Competition in Southeast Asia
* BetaLife wins top prize with its potential to provide regenerative medicines to patients with severe diabetes inSoutheast Asia. * Cytiva's BioChallenge aims to support the innovation of biotech startups. Singapore, June 7, 2023 /PRNewswire/ -- Cytiva recognizes the talent, resource and scal...
2023-06-07 12:00
2739
First Medical Product in New Hybrid Light-Curable Adhesive Platform from Dymax
Offers Rapid Curing in Light or Darkness to a Wider Range of Substrates SINGAPORE, June 7, 2023 /PRNewswire/ -- Dymax, a leading manufacturer of rapid curing materials and equipment, is excited to announce the release of HLC-M-1000, the first product in its new Hybrid Light-Curable (HLC) series ...
2023-06-07 10:45
2632
Samyang Signs Partnership Agreement with Yxintent, China for Dermal Filler Lafullen®
* Yxintent will exclusively sell Lafullen® after conducting clinical trials and approval inChina, with Samyang supplying products worth KRW 100 billion over the next five years * Long-lasting biodegradable dermal filler with natural volume and long-lasting effects, proven safety and efficacy ...
2023-06-07 09:30
3991
Translumina bolsters its German presence with acquisition of Lamed GmbH
NEW DELHI and MUNICH, June 7, 2023 /PRNewswire/ -- Translumina, a global leader in interventional cardiovascular medical devices with manufacturing presence in Germany and India, today announced the acquisition of Munich-based Lamed GmbH. With this acquisition, Translumina has taken a step further...
2023-06-07 09:00
3256
Sunway Medical Centre is Malaysia's leading hospital in paediatrics, according to Best Specialized Hospitals Asia Pacific Newsweek rankings
The hospital also ranks highly in the areas of Oncology, Neurology and Cardiology SUBANG JAYA, Malaysia, June 7, 2023 /PRNewswire/ -- Sunway Medical Centre (SMC), Sunway City, the flagship quaternary hospital under the Sunway Healthcare Group, ranked the top for paediatrics inMalaysia, in the Be...
2023-06-07 08:30
2814
Colorcon, Inc. Invests in a New Film Coating Manufacturing Plant in Malaysia
Establishment of an eighth Colorcon film coating facility meets the expanding needs of the pharmaceutical and nutritional sectors inSoutheast Asia HARLEYSVILLE, Pa., June 6, 2023 /PRNewswire/ -- Colorcon, Inc. is proud to formally announce its investment in a new manufacturing plant in Johor Stat...
2023-06-06 20:00
4303
LiveSpo represents Vietnam to announce the world's first spore probiotics in nasal spray form at the BIO International Convention
BOSTON, June 6, 2023 /PRNewswire/ -- LiveSpo is the first representative from Vietnam to participate in the BIO International Convention, an exhibition showcasing breakthrough biotechnology solutions, held inBoston, USA. This demonstrates the remarkable development of the Vietnamese pharmaceutica...
2023-06-06 19:40
2612
Midea Healthcare Unveils New Solutions for Smart Healthcare Market
FOSHAN, China, June 6, 2023 /PRNewswire/ -- Midea Healthcare, as one of primarily business for Midea Group (000333.SZ), recently held a new product launch event in CMEF 2023 with its five medical industry consortia – Wandong (WDM), KUKA, Midea Biomedical, Swisslog Healthcare, and Midea Building ...
2023-06-06 16:10
3118
Biosyngen's Cell Therapy BRG01 Granted Orphan Drug Designation by the U.S. FDA for Treatment of Nasopharyngeal Cancer
SINGAPORE, June 6, 2023 /PRNewswire/ -- Jun. 1st, 2023, Biosyngen Pte. Ltd. (hereinafter as "Biosyngen") announced that the U.S. Food and Drug Administration's (FDA) Office of Orphan Products Development (OOPD) has granted to its application, for immune cell therapy BRG01for the treatment of nas...
2023-06-06 12:58
2738
Alphamab Oncology updated clinical research data for KN026 in Combination with KN046 in HER2-Positive Solid Tumors at the ASCO 2023 annual meeting
* As of November 10, 2022, 26 patients with HER2-positive unresectable or metastatic solid tumors (other than breast cancer and gastric/gastroesophageal junction cancer) were enrolled, 92.3% of whom had received ≥2L prior systemic therapy. The objective response rate (ORR) was 53.8% with 6.8 mo...
2023-06-06 09:06
2431
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8873
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7709